Proteins are made in the cell at ribosomes, which assemble amino acids into a chain based on instructions copied from DNA and delivered by messenger RNA. In eukaryotes, this happens in two places: free ribosomes in the cytoplasm and ribosomes bound to the endoplasmic reticulum. Each location routes proteins to different destinations. The process from gene to finished protein involves more steps than the phrase "proteins are made at the ribosome" suggests.

Translation: the core mechanism

Translation is the step where a ribosome reads messenger RNA (mRNA) and links amino acids into a protein. The ribosome is not a single machine but two subunits, large and small, that clamp around the mRNA strand. In human cells, the large subunit contains the catalytic center that forms peptide bonds, and the small subunit handles decoding.

The decoding works in three-base units called codons. Each codon specifies one amino acid, and transfer RNA (tRNA) molecules carry the matching amino acid into the ribosome. The ribosome moves along the mRNA one codon at a time, adding roughly two to twenty amino acids per second depending on the organism and conditions. A typical human protein of 400 amino acids therefore takes about 30 seconds to two minutes to synthesize.

Three sites inside the ribosome coordinate this work. The A site receives each new tRNA, the P site holds the growing chain, and the E site releases spent tRNA. Peptide bond formation itself is catalyzed by ribosomal RNA rather than protein, which makes the ribosome a ribozyme. That detail matters because it shows the ribosome is not just a scaffold but a chemically active machine.

Initiation, elongation, and termination are the three phases. Initiation depends on a start codon and on initiation factors that position the ribosome correctly. Elongation cycles through the A, P, and E sites. Termination occurs when a stop codon enters the A site, prompting release factors to free the finished chain.

Where in the cell: two ribosome populations

Eukaryotic cells run two parallel translation systems, and the split is not cosmetic. Free ribosomes float in the cytosol, and bound ribosomes attach to the rough endoplasmic reticulum (ER). Both make proteins, but they serve different destinations. The figure most often cited is that the ER carries roughly a third of total protein synthesis in a typical secretory cell, though the split varies widely by cell type.

Free ribosomes synthesize proteins that will stay in the cytosol or go to the nucleus, mitochondria, or peroxisomes. These proteins usually fold after synthesis is complete. Bound ribosomes synthesize proteins destined for the ER lumen, the Golgi apparatus, lysosomes, the plasma membrane, or secretion outside the cell.

The sorting decision happens during translation, not before it. A signal sequence at the N-terminus of the growing chain is recognized by a signal recognition particle (SRP). The SRP pauses translation and docks the ribosome onto the ER membrane. That is why a ribosome that starts free can end up bound, and why "bound" and "free" describe a ribosome's location at one moment, not a permanent identity.

Bacteria have a different arrangement. They lack a nucleus and internal membrane compartments, so translation happens in the cytoplasm, often coupled directly to transcription. A bacterial ribosome can begin translating an mRNA while RNA polymerase is still making it.

Quantified context: how much and how fast

Scale helps here. A single human cell contains roughly one to ten million ribosomes, depending on cell type and growth state. A liver cell, which manufactures large volumes of secreted protein, sits near the upper end. A resting neuron sits lower.

rRNA makes up about 80 percent of total cellular RNA by mass, which reflects how much of a cell's transcriptional output serves ribosome production. Ribosome assembly happens in the nucleolus, where rRNA is transcribed and folded and then packaged with ribosomal proteins imported from the cytoplasm.

The energy cost is substantial. Each peptide bond consumes the equivalent of about four high-energy phosphate bonds across the full elongation cycle. A cell making ten million proteins per minute, as some rapidly dividing cells approximate, spends a large fraction of its ATP budget on translation.

Timing matters for another reason. mRNA half-lives in mammalian cells often fall between 30 minutes and several hours, so translation must proceed promptly after transcription. Proteins synthesized on the ER reach the Golgi within minutes, and secreted proteins typically exit the cell within 30 to 60 minutes of synthesis.

Timeline of a secreted protein

Stage Location Approximate time
Transcription Nucleus 20-60 seconds for a typical gene
mRNA processing and export Nucleus to cytosol 5-30 minutes
Initiation of translation Cytosol or ER surface Seconds
Elongation (400-amino-acid chain) Ribosome 30 seconds to 2 minutes
SRP docking to ER ER membrane Seconds to minutes
Co-translational folding ER lumen 1-5 minutes
ER quality control and export ER to Golgi 10-30 minutes
Golgi processing Golgi apparatus 10-30 minutes
Secretion Plasma membrane Minutes to hours depending on cargo

These intervals are ranges, not fixed values. They vary with cell type, temperature, and metabolic state.

Edge cases and professional caveats

Mitochondria and chloroplasts carry their own ribosomes, which more closely resemble bacterial ribosomes than cytosolic ones. This is not a curiosity; it explains why certain antibiotics that target bacterial ribosomes can affect mitochondrial translation and cause side effects in patients.

The nucleolus is the ribosome factory, not a protein factory. It builds the ribosomes that will do the protein work. Confusing these two structures is a common error.

Some proteins are made without a ribosome at all. Short peptides can be assembled by non-ribosomal peptide synthetases, and a handful of specialized cellular processes run on ribosome-independent chemistry. These are exceptions, not the rule.

Membrane-bound ribosomes are not a distinct subtype. The same ribosome can be free in one moment and ER-bound in the next, depending on what mRNA it encounters.

A professional caveat worth stating plainly: translation is regulated in ways textbooks often skip. MicroRNAs can suppress translation of specific mRNAs, and mRNA secondary structure can slow elongation. A cell can therefore control protein output at the step after transcription, which means "where proteins are made" is not the same question as "where protein amount is decided."

Red flags when reading about protein synthesis: Claims that all proteins are made on the ER or all on free ribosomes are oversimplifications. Statements that ribosomes are permanent residents of one compartment ignore the signal-recognition mechanism. Treatments that promise to "boost ribosome function" without specifying which ribosome population are not clinically meaningful. The number of ribosomes per cell varies by orders of magnitude, so any single figure should be read as a range. Ribosome biogenesis is one of the most energy-expensive processes in a growing cell, which limits how much any intervention could plausibly change.

Common misconceptions and how the cell actually sorts proteins

The largest misconception is that free and bound ribosomes are separate organelle classes. They are not. They are the same machine in different locations, and the distinction is functional rather than structural.

A second misconception is that protein synthesis begins after mRNA is fully processed. In bacteria, transcription and translation are coupled, and in eukaryotes some processing occurs concurrently with transcription. The cell is not a sequential assembly line.

A third misconception is that proteins fold only after complete synthesis. Many secreted proteins fold as they enter the ER, a process called co-translational folding. This affects how quality control detects misfolded proteins.

The cytoplasm itself is crowded. Protein concentration there is estimated in the range of 200 to 300 mg/mL, which means ribosomes, tRNA, and translation factors operate in a dense environment rather than a dilute solution. That crowding speeds some reactions and slows others.

Table: where different protein classes are made and what happens next

Protein destination Synthesis site Subsequent route
Cytosolic enzyme Free ribosome in cytosol Folds in cytosol; often no further routing
Nuclear protein Free ribosome in cytosol Imported through nuclear pores
Mitochondrial protein Free ribosome in cytosol Imported through mitochondrial membranes
Secreted protein ER-bound ribosome ER lumen, Golgi, then out of the cell
Membrane protein ER-bound ribosome ER, Golgi, then plasma membrane
Lysosomal enzyme ER-bound ribosome ER, Golgi, then lysosome

A countersintuitive point: a protein destined for the cell surface is made in the cytosol first, with only its leading end inserted into the ER as it grows. The ribosome does not sit inside the ER. It docks on the outside, and the chain threads through a channel into the lumen.

Practical actions: what to do with this framework

If you are studying cell biology, use the destination-first approach. Identify where a protein acts, then trace backward to the ribosome population that made it. This is faster than memorizing lists.

If you are interpreting a lab result that measures protein synthesis, check which compartment was sampled. Cytosolic extracts and ER fractions contain different mixes of nascent chains.

If you are reading pharmacology, note that antibiotics targeting the bacterial ribosome act on translation, not on protein folding or ER routing. That distinction shapes side-effect profiles.

Concrete steps: Locate the signal sequence when given a protein sequence; its presence points to the ER pathway. Check whether the protein has a nuclear localization signal or mitochondrial targeting peptide. Distinguish steady-state location from synthesis site; they are often different. Use the rough versus smooth ER distinction only as a starting point, not as a rigid rule. Treat ribosome counts as ranges and cite cell type when quoting them.

Limits of what this explains

This account covers the core pathway and its main routing rules. It does not resolve every open question. The precise kinetics of SRP docking, the role of ribosome heterogeneity in selecting which mRNAs get translated, and the regulation of translation in specific disease states remain active research areas.

What can be said with confidence is structural: ribosomes are the site of protein synthesis, and in eukaryotic cells they operate from two locations with different downstream consequences. The rest is detail that depends on cell type, developmental stage, and physiology.